semaglutide maintenance dose for weight loss New Evidence on Timing: Why a 4‑Hour Window May Matter More Than Morning vs Evening Ozempic Dosing: Understanding Frequency for

This is an uncomfortable reality that most GLP-1 discussions avoid

The dual GIP/GLP-1 receptor agonist tirzepatide is among the furthest developed multi-agonists for diabetes care and has so far displayed promising nephroprotective effects

If these findings translate clinically, targeting #TXNIP could represent a fundamentally new approach to weight maintenance after #weightloss therapy, an area where there are currently few options

In these cases, PlexusDx offers alternative delivery methods and dual-compound options

And for patients who do eventually have surgery, GLP-1s are increasingly part of the picture before and after